PerkinElmer, Inc. (United States)
(NYSE : PKI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -3.36%560.841.0%$877.55m
DHRDanaher Corp. -3.16%271.590.7%$739.45m
ABTAbbott Laboratories -3.43%121.520.8%$678.00m
MDTMedtronic Plc -2.94%102.500.6%$643.17m
ISRGIntuitive Surgical, Inc. -1.01%266.820.8%$479.22m
ALGNAlign Technology, Inc. -0.81%459.036.4%$354.10m
DXCMDexCom, Inc. -1.50%415.797.8%$338.86m
SYKStryker Corp. -3.44%245.911.3%$312.08m
BSXBoston Scientific Corp. -2.49%41.901.0%$303.68m
BDXBecton, Dickinson & Co. -3.22%256.101.0%$293.61m
AAgilent Technologies, Inc. -2.03%134.731.6%$224.34m
EWEdwards Lifesciences Corp. -3.99%108.160.4%$211.09m
IDXXIDEXX Laboratories, Inc. 0.05%502.223.8%$206.45m
ZBHZimmer Biomet Holdings, Inc. -1.16%121.121.7%$194.59m
PKIPerkinElmer, Inc. (United States) -2.29%170.882.4%$176.76m

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.